Arctic Securities is acting as financial advisor in relation to the rights issue in Enorama Pharma AB (publ) of SEK 25m. Enorama Pharma AB (publ) is referred to as “Enorama Pharma” or “the Company”.Shareholders have pre-emptive rights to subscribe for shares. Ten (10) existing shares held on the record date of October 30, 2018, entitles to one (1) new share. Subscription price of SEK 52 SEK per share. The subscription period runs 1 November – 16 November, 2018. The rights issue is secured up to 85 percent through subscription- and guarantee undertakings. A Swedish memorandum and subscription note will be available before the subscription period on Enorama Pharma’s website, www.enorama.se and Arctic Securities website.